Total income rose 22.3% YoY to ₹501 crore, marking the company’s highest-ever quarterly revenue, while EBITDA climbed 28.9% to ₹141 crore, with margins at 28.2%. Revenue from operations grew 20.8% to ₹487 crore, with India operations contributing ₹440 crore, up 21.4% from a year earlier.
The Chennai-based company expanded its network to 249 facilities across 10 countries, adding 13 new centres during the quarter, including its first outlet in Delhi. The company performed 78,882 surgeries in the three months to June, a 16% rise YoY, and served over 7 lakh patients.
Commenting on the Q1 performance, CEO Dr. Adil Agarwal said the strong performance was “driven by healthy growth across our network” and supported by cost discipline. He added that the company remains focused on expanding its footprint, investing in advanced technologies, and delivering superior clinical outcomes.
